Stichting Access to Medicine Foundation
Date of Award
Type 1 Diabetes, Improve Outcomes
Term of Grant
Expanding Access to T1D Care
Support to conduct research and engagement to incentivize healthcare companies to increase access to insulin and other diabetes products, support global efforts to ensure equitable access to comprehensive, affordable, and quality treatment for people living with type 1 diabetes (T1D) in low- and middle-income countries (LMICs) and stimulate investors to steward and track company progress.